You have 9 free searches left this month | for more free features.

Janus Kinase Inhibitors

Showing 1 - 25 of 6,615

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Idiopathic Inflammatory Myopathies Trial in Beijing (tofacitinib)

Recruiting
  • Idiopathic Inflammatory Myopathies
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Oct 9, 2022

Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

Not yet recruiting
  • Rheumatoid Arthritis
  • Observation
  • (no location specified)
Oct 8, 2022

Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Abrocitinib 200 MG Oral Tablet
  • +2 more
  • (no location specified)
Feb 21, 2023

COVID-19 Pneumonia Trial in Bangladesh (Baricitinib, Dexamethasone, Remdesivir)

Recruiting
  • COVID-19 Pneumonia
  • Comilla, Bangladesh
  • +6 more
Aug 25, 2021

Janus Kinase Inhibitor Therapy in Ulcerative Colitis

Terminated
  • Ulcerative Colitis
  • Janus Kinase Inhibitor
  • Amsterdam, North Halland, Netherlands
    Amsterdam Medical Center, IBD Center
Dec 14, 2021

Alopecia Areata Trial in Sohag (Janus Kinase 1 and 2)

Recruiting
  • Alopecia Areata
  • Janus Kinase 1 and 2
  • Sohag, Egypt
    Sohag University hospitals
May 12, 2023

Abatacept, Treatment Compliance, Rheumatoid Arthritis Trial in Hangzhou (Janus Kinase Inhibitor, Abatacept)

Recruiting
  • Abatacept
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Jul 5, 2022

Granuloma Annulare Trial in New Haven (Abrocitinib 200 mg)

Not yet recruiting
  • Granuloma Annulare
  • Abrocitinib 200 mg
  • New Haven, Connecticut
    Yale University
Dec 19, 2022

Chronic Kidney Diseases Trial in Durham (Baricitinib, Placebo)

Recruiting
  • Chronic Kidney Diseases
  • Durham, North Carolina
    Duke Research at Pickett Road
Dec 15, 2022

Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)

Recruiting
  • Sjogren's Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 24, 2022

Sarcoidosis Trial in New Haven (Abrocitinib 200 mg)

Not yet recruiting
  • Sarcoidosis
  • Abrocitinib 200 mg
  • New Haven, Connecticut
    Yale University
Jan 24, 2023

COVID-19 Trial in Halifax (Baricitinib (janus kinase inhibitor), Remdesivir (antiviral) + barictinib (janus kinase inhibitor),

Recruiting
  • COVID-19
  • Baricitinib (janus kinase inhibitor)
  • +3 more
  • Halifax, Nova Scotia, Canada
    Nova Scotia Health Authority
Mar 9, 2022

Cancer Trial in Changsha (Protein Kinase Inhibitor)

Recruiting
  • Cancer
  • Protein Kinase Inhibitor
  • Changsha, Hunan, China
    Central South University
Jun 23, 2022

Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

Not yet recruiting
  • Tyrosine Kinase Inhibitors
  • Chronic Myeloid Leukemia
  • treatment of TKI in CML
  • Poitiers, France
    Chu Poitiers
Feb 21, 2023

Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

Recruiting
  • Breast Cancer
  • CT scans
  • DEXA scan
  • Bronx, New York
    Montefiore Medical Center
Jan 6, 2023

Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

Recruiting
  • Breast Cancer Stage IV
  • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
  • Mansoura, Dakahlia, Egypt
    Oncology center mansoura university
Jan 1, 2023

Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • multi-kinase inhibitors in combination with bevacizumab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes

Active, not recruiting
  • Patients Diagnosed as Chronic Meyloid Leukemia
  • Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
  • Assiut, Egypt
    Assiut University Hospital
Feb 19, 2022

Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

Recruiting
  • Atrial Fibrillation
  • +4 more
  • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
  • New Hyde Park, New York
    Northwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022

Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)

Recruiting
  • Non Small Cell Lung Cancer
  • Metformin Hydrochloride
  • Placebo
  • Mexico City, Mexico
    Instituto Nacional de Cancerologia
Jul 21, 2022

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Rotterdam, Netherlands
      Erasmus MC
    Feb 2, 2022

    Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

    Recruiting
    • Olverembatinib
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022